Profil
Fredrick D.
Cobb, M.S.
is a finance professional with over thirty years of experience in senior financial positions in the biotechnology, consumer product and pharmaceutical industries.
At Emisphere Technologies, Inc. Mr. Cobb served as Principal Financial Officer where he was responsible for all aspects of finance, accounting and SEC reporting.
Prior to that Mr. Cobb served as Vice President/Chief Financial Officer of MetaMorphix, Inc. a private biotechnology company where he successfully assisted in establishing and managing a start-up research operation by securing financing, and developing and implementing business plans.
Mr. Cobb has also served as a consultant to Insight Consulting Group where he provided integrated information solutions and project management in finance and accounting.
Mr. Cobb served as Vice President/Corporate Controller for Smith Corona Corporation with a role that encompassed all facets of accounting and financial (SEC) reporting.
Mr. Cobb spent seven years as the Corporate Controller and later as the General Manager and Executive Officer at BIC Corporation where he was in charge of SEC reporting functions, IT, HR, sales, marketing, manufacturing, distribution, and engineering.
At Bristol-Myers Squibb Company for 12 years, Mr. Cobb served in several senior financial positions where he was responsible for financial reporting, costing, budgeting, planning, analysis, policies and procedures across several pharmaceutical divisions.
Mr. Cobb received his M.S.
in Accounting from Seton Hall University in 1997 and a B.S.
in Business Management from Cornell University.
Anciens postes connus de Fredrick D. Cobb
| Sociétés | Poste | Fin |
|---|---|---|
| AYALA PHARMACEUTICALS, INC. | Directeur Financier/CFO | - |
Metaphore Pharmaceuticals, Inc.
 Metaphore Pharmaceuticals, Inc. BiotechnologyHealth Technology Metaphore Pharmaceuticals, Inc. is a pharmaceutical company which discovers, develops and markets drugs that prevent and treat pain, autoimmune disorders and inflammation. The company leverages its expertise in chemistry and biology to discover and develop small molecule compounds that mimic the activity of human enzymes. The company's compounds mimic the function of superoxide dismutase (SOD), a beneficial enzyme that serves an important protective role in the body by removing superoxide, a toxic free radical that can damage cells and tissues. Superoxide anions are implicated in a variety of diseases associated with pain and inflammation. The company is headquartered in St. Louis, MO. | Comptroller/Controller/Auditor | - |
Formation de Fredrick D. Cobb
| Seton Hall University | Graduate Degree |
| Cornell University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Metaphore Pharmaceuticals, Inc.
Metaphore Pharmaceuticals, Inc. BiotechnologyHealth Technology Metaphore Pharmaceuticals, Inc. is a pharmaceutical company which discovers, develops and markets drugs that prevent and treat pain, autoimmune disorders and inflammation. The company leverages its expertise in chemistry and biology to discover and develop small molecule compounds that mimic the activity of human enzymes. The company's compounds mimic the function of superoxide dismutase (SOD), a beneficial enzyme that serves an important protective role in the body by removing superoxide, a toxic free radical that can damage cells and tissues. Superoxide anions are implicated in a variety of diseases associated with pain and inflammation. The company is headquartered in St. Louis, MO. | Health Technology |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
